Soy-based compound may help lower tumor cell accumulation in colorectal cancer
Washington, April 12(ANI): Mount Sinai researchers have identified a soy-based treatment for colorectal cancer, a promising therapy for treatment-resistant ovarian cancer and a new drug target for advanced prostate cancer.
The development of colorectal cancer (CRC) is largely driven by cellular signaling in the Wnt pathway, a network of proteins critical to cellular growth. Hyperactivity of the Wnt signaling pathway occurs in more than 85 percent of colon and rectal cancers.